关注
Chaitanya Churi
Chaitanya Churi
未知所在单位机构
在 apple.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing
JS Ross, K Wang, L Gay, R Al-Rohil, JV Rand, DM Jones, HJ Lee, ...
The oncologist 19 (3), 235-242, 2014
5322014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications
CR Churi, R Shroff, Y Wang, A Rashid, HSC Kang, J Weatherly, M Zuo, ...
PloS one 9 (12), e115383, 2014
4892014
HER2/neu-directed therapy for biliary tract cancer
M Javle, C Churi, HSC Kang, R Shroff, F Janku, R Surapaneni, M Zuo, ...
Journal of hematology & oncology 8, 1-9, 2015
2482015
Overexpression of the HER2/neu gene: a new therapeutic possibility for patients with advanced gallbladder cancer
I Roa, G de Toro, K Schalper, X de Aretxabala, C Churi, M Javle
Gastrointestinal cancer research: GCR 7 (2), 42, 2014
1322014
Molecular characterization of gallbladder cancer using somatic mutation profiling
M Javle, A Rashid, C Churi, S Kar, M Zuo, AK Eterovic, ...
Human pathology 45 (4), 701-708, 2014
972014
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
M Zuo, A Rashid, C Churi, JN Vauthey, P Chang, Y Li, MC Hung, D Li, ...
British journal of cancer 112 (6), 1042-1051, 2015
512015
A web-based tool for patient triage in emergency department settings: validation using the emergency severity index
P Elias, A Damle, M Casale, K Branson, N Peterson, C Churi, ...
JMIR Medical Informatics 3 (2), e3508, 2015
142015
Sexual behaviour among truck drivers halting at Kalamboli Truck Terminal, Navi Mumbai
C Churi, S Anjenaya
Australasian Medical Journal (Online), 271, 2010
62010
Comprehensive genomic profiling of gallbladder adenocarcinoma and frequent genomic-derived targets of therapy.
P Stephens, K Wang, NA Palma, J Chmielecki, RT Shroff, C Churi, ...
Journal of Clinical Oncology 32 (15_suppl), 4142-4142, 2014
32014
Results of an HIV stigma reduction intervention on a university campus
SA Millimet, B Miller, MW Ross, P Samson, C Churi
International Journal of Child and Adolescent Health 6 (3), 297, 2013
32013
BAP1 mutation-associated cholangiocarcinoma: An aggressive disease.
D Anand, C Churi, A Rashid, RT Shroff, M Zuo, C Conrad, JN Vauthey, ...
Journal of Clinical Oncology 33 (3_suppl), 420-420, 2015
22015
Evaluation of an HIV anti-stigma campaign
SA Millimet, B Miller, MW Ross, P Samson, C Churi
Child and Adolescent Health Issues (A Tribute to the Pediatrician Donald E …, 2015
12015
Comparison of microRNA (MiRNA) expression profiles between opisthorchis viverrini-associated cholangiocarcinoma (OV-CCA) and non-opisthorchis viverrini-associated …
S Tanasanvimon, A Rashid, S Wongkham, C Churi, Z Tong, ...
Journal of Clinical Oncology 31 (4_suppl), 206-206, 2013
12013
Metadata Correction: A Web-Based Tool for Patient Triage in Emergency Department Settings: Validation Using the Emergency Severity Index
P Elias, A Damle, M Cassale, K Branson, N Peterson, C Churi, ...
JMIR Medical Informatics 3 (3), e4816, 2015
2015
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
RT Shroff, C Churi, A Rashid, L Mishra, M Zuo, AO Kaseb, F Janku, ...
Journal of Clinical Oncology 32 (3_suppl), 209-209, 2014
2014
Abstract C171: Novel therapeutic strategies targeting the hedgehog signaling pathway and mTOR pathway in biliary tract cancer (BTC).
M Zuo, A Rashid, C Churi, MC Hung, M Javle
Molecular Cancer Therapeutics 12 (11_Supplement), C171-C171, 2013
2013
Abstract B132: Next generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
CR Churi, A Rashid, R Shroff, L Mishra, M Zuo, A Kaseb, F Janku, ...
Molecular Cancer Therapeutics 12 (11_Supplement), B132-B132, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–17